Published on
August 10, 2020
- 00:00 GMT
AnHeart Announces Entry into Series A+ Equity Financing Agreements
HANGZHOU, China and NEW YORK, Aug. 09, 2020 (GLOBE NEWSWIRE) -- AnHeart Therapeutics, Co., Ltd. (“AnHeart”), a clinical stage oncology company focused on underserved patients in global markets, has entered into agreements to raise over 20 million USD in an …
Distribution channels:
Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry
...
